Token Benefits
Traditionally, drug discovery and development (“3D”) is a time-consuming, costly and high-risk business
Complied with
Cryptographic ERC-1404
Issued by Smart
Pharmaceutical Limited
Partnership
Value backed by Intellectual Property Rights and Related Cashflows of Therapeutic Assets Generated from
Smart-ACTᵀᴹ
SMPT Token is backed by
asset pipeline of Smart-ACTᵀᴹ
Potential Year-on-Year (“YoY”)
valuation subject to the following:

Commercialisation and Out-licensing monetisation strategies of drug-target pairs; AND

The accumulation of a growing library of pairs / drug candidates each year

Smart Pharma Explained
About SMPT
Token Symbol
SMPT
Token Type
ERC-1404 security compliant tokens with ERC-20 and ERC-233 compliance on the Ethereum blockchain
Total Token Supply
1,000,000,000 (100%)
Tokens Available for Public
700,000,000 (70%)
Retention by Issuer’s Staff, Partners & Ecosystem
50,000,000 (5%)
Retention by Issuer
250,000,000 (25%)
Secondary Market
To be disclosed
Issuer
Smart Pharmaceutical Limited Partnership
Technology Partner
SMPT token is co-developed together with Aenco
Solutions (www.aencoin.com)